LSNE Appoints New COO - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

LSNE Appoints New COO



Untitled Document

Lyophilization Services of New England (LSNE), a New Hampshire based contract-manufacturing organization, has appointed Shawn Cain as COO, a new position within the company. Cain joined LSNE in 2012 as vice- president of sterile manufacturing. In his new role, Cain will be responsible for overseeing day-to-day operations and ensuring companywide alignment with the corporate goals. Cain will report to Matthew Halvorsen, president and CEO of LSNE. Cain's 28-year career includes experience in the pharmaceutical, biotech, and medical device industries. Cain has held management positions within operations at Organogenesis, Formatech, Arbios Systems, and Becton Dickinson.

Source: LSNE

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
31%
Breakthrough designations
8%
Protecting the supply chain
42%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here